Dose-response envelope for Escherichia coli. Quantitative Microbiology. 2, 141-163.
(2000). Dose-response envelope for Escherichia coli O157:H7. Quantitative Microbiology. 2, 141-163.
(2000). Effect of a boil water notice on behaviour in the management of a water contamination incident. Communicable Disease and Public Health. 3, 56–59.
(2000). Future health assessment and risk-management integration for infectious diseases and biological weapons for deployed US forces. Strategies to Protect the Health of Deployed: Assessing Health Risks Deployed US Forces. 59–112.
(2000). (2000). Pathogenesis of and immunity to melioidosis. Acta Tropica. 74, 2.
(2000). Pseudomonas aeruginosa folliculitis after shower/bath exposure. International journal of dermatology. 39, 270–273.
(2000). Q fever epidemiology and pathogenesis. Microbes and Infection. 2,
(2000). (2000). (2000). (2000). Role of EspB in Experimental Human Enteropathogenic Escherichia coli Infection. Infection and Immunity. 68, 6.
(2000). (2000). Surveillance for waterborne-disease outbreaks, United States, 1997-1998. Morbidity and Mortality Weekly Report. 49,
(2000). The beta Poisson dose-response model is not a single-hit model. Risk Analysis. 20,
(2000). (2000). Transmission of viral respiratory infections in the home. The Pediatric Infectious Disease Journal. 19, 97-102.
(2000). Comparison of Imipenem and Ceftazidime as Therapy for Severe Melioidosis. Clinical Infectious Diseases. 29, 2.
(1999). Cultural theory and risk: a review. Health, risk & society. 1, 71-90.
(1999). Development and Validation of Dose-Response Relationship for Listeria monocytogenes. Quantitative Microbiology. 1, 89-102.
(1999). Distribution and seasonality of microbial indicators and thermophilic campylobacters in two freshwater bathing sites on the River Lune in northwest England. Journal of Applied Microbiology. 87(6),
(1999). Dose response models for infectious gastroenteritis. Risk Analysis. 19(6),
(1999). Dose response models for infectious gastroenteritis. Risk Analysis. 19, 1251–1260.
(1999). (1999). Experimental Staph Vaccine Broadly Protective in Animal Studies. National Institute of Allergy and Infectious Diseases.
(1999).